LOADING
Comparing Pfizer Inc (PFE) and AT&T Inc (T) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | PFE | T |
|---|---|---|
| Price | $25.33 | $24.04 |
| Change Today | -1.63% | -2.47% |
| Market Cap | $148.0B | $171.3B |
| P/E Ratio | 19.8 | 8.1 |
| Forward P/E | 8.8 | 10.9 |
| PEG Ratio | 13.77 | 1.76 |
| EPS | $1.31 | $3.04 |
| Revenue Growth (YoY) | 5.4% | 2.9% |
| Profit Margin | 11.8% | 16.9% |
| Return on Equity | 8.3% | 18.4% |
| Dividend Yield | 6.65% | 4.49% |
| Beta | 0.30 | 0.42 |
| 52-Week High | $28.28 | $29.14 |
| 52-Week Low | $20.98 | $22.71 |
| Volume | 1.3M | 1.7M |
AT&T Inc is the larger company by market capitalization. AT&T Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. AT&T Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.